Bing Li

5.7k total citations
216 papers, 3.1k citations indexed

About

Bing Li is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Bing Li has authored 216 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 59 papers in Pulmonary and Respiratory Medicine and 42 papers in Molecular Biology. Recurrent topics in Bing Li's work include Mycobacterium research and diagnosis (29 papers), Lung Cancer Treatments and Mutations (26 papers) and Tuberculosis Research and Epidemiology (23 papers). Bing Li is often cited by papers focused on Mycobacterium research and diagnosis (29 papers), Lung Cancer Treatments and Mutations (26 papers) and Tuberculosis Research and Epidemiology (23 papers). Bing Li collaborates with scholars based in China, United States and Germany. Bing Li's co-authors include Haiqing Chu, Zhemin Zhang, Liyun Xu, Minjie Sheng, Weifang Wang, Shengxiang Ren, Meiping Ye, Qi Guo, Meihua Gao and Lan Zhao and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Bing Li

196 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Li China 30 786 783 739 497 452 216 3.1k
Libo Wang China 29 770 1.0× 1.2k 1.5× 282 0.4× 231 0.5× 512 1.1× 124 3.2k
Chee‐Kiat Tan Singapore 33 277 0.4× 967 1.2× 1.4k 1.8× 730 1.5× 367 0.8× 167 4.2k
George Sourvinos Greece 36 534 0.7× 1.2k 1.6× 1.1k 1.5× 701 1.4× 789 1.7× 140 4.1k
Masaki Fujita Japan 37 1.9k 2.4× 1.1k 1.5× 621 0.8× 267 0.5× 389 0.9× 240 5.0k
Richard T. Bryan United Kingdom 41 664 0.8× 802 1.0× 633 0.9× 975 2.0× 698 1.5× 168 5.7k
Edward Yu United States 43 1.0k 1.3× 1.6k 2.0× 779 1.1× 659 1.3× 1.5k 3.4× 191 6.2k
Hans‐Peter Marti Switzerland 41 402 0.5× 702 0.9× 377 0.5× 651 1.3× 291 0.6× 187 5.7k
Dirk Theegarten Germany 32 1.4k 1.8× 564 0.7× 374 0.5× 179 0.4× 578 1.3× 186 3.1k
Vincenzo Esposito Italy 33 765 1.0× 1.0k 1.3× 410 0.6× 392 0.8× 1.1k 2.5× 147 3.6k
Dirk M. Elston United States 28 251 0.3× 685 0.9× 1.1k 1.5× 708 1.4× 747 1.7× 312 4.2k

Countries citing papers authored by Bing Li

Since Specialization
Citations

This map shows the geographic impact of Bing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Li more than expected).

Fields of papers citing papers by Bing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Li. The network helps show where Bing Li may publish in the future.

Co-authorship network of co-authors of Bing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Li. A scholar is included among the top collaborators of Bing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Li. Bing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Junsheng, et al.. (2025). An enoyl-ACP reductase inhibitor, NITD-916, expresses anti- Mycobacterium abscessus activity. Antimicrobial Agents and Chemotherapy. 69(7). e0024925–e0024925.
2.
Li, Bing, Ke Zhang, Qin Chen, et al.. (2025). Discovery of a Novel MNK Inhibitor (NSP-1047) with In Vivo Anti-acute Myeloid Leukemia Activity. Journal of Medicinal Chemistry. 68(15). 15617–15635.
3.
Cao, Weiya, Bing Li, Haibo Jin, et al.. (2025). S100a8 inhibitor Paquinimod attenuates coal dust-induced pulmonary fibrosis via blocking neutrophils-S100a8-Tlr4-macrophages signaling axis. International Immunopharmacology. 161. 115020–115020.
4.
5.
Yao, Lingling, et al.. (2024). Correlation between prognosis and peripheral blood levels of NLRP3 and triglyceride-glucose index after myocardial ischemia-reperfusion injury. Journal of Cardiothoracic Surgery. 19(1). 553–553. 2 indexed citations
6.
Ma, Qian, et al.. (2024). Dextran sulfate inhibits proliferation and metastasis of human gastric cancer cells via miR-34c-5p. Heliyon. 10(15). e34859–e34859. 1 indexed citations
7.
Fan, Junsheng, et al.. (2024). TBAJ-587, a novel diarylquinoline, is active against Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy. 68(12). e0094524–e0094524. 1 indexed citations
8.
Fan, Junsheng, et al.. (2023). GlnR activated transcription of nitrogen metabolic pathway genes facilitates biofilm formation by mycobacterium abscessus. International Journal of Antimicrobial Agents. 63(1). 107025–107025. 11 indexed citations
9.
Li, Bing, Siyuan He, Junsheng Fan, et al.. (2023). Impaired ESX‐3 Induces Bedaquiline Persistence in Mycobacterium abscessus Growing Under Iron‐Limited Conditions. Small Methods. 7(9). e2300183–e2300183. 2 indexed citations
10.
Li, Bing, Jing Zhang, Yang Huang, et al.. (2023). A conserved N protein nano‐vaccine of COVID‐19 exerts potent and cross‐reactive humoral and cellular immune responses in mice. Journal of Medical Virology. 95(9). e29115–e29115. 2 indexed citations
11.
Li, Yongqi, et al.. (2023). Analysis of the epidemiological characteristics of posterior malleolus fracture in adults. Journal of Orthopaedic Surgery and Research. 18(1). 507–507. 1 indexed citations
12.
Zhang, Qi, Weichun Tang, Zulfeqhar A. Syed, et al.. (2023). Host heparan sulfate promotes ACE2 super-cluster assembly and enhances SARS-CoV-2-associated syncytium formation. Nature Communications. 14(1). 5777–5777. 10 indexed citations
13.
Li, Bing, Jinqin Liu, Yujiao Jia, et al.. (2017). Clinical Features and Biological Implications of U2AF1 Mutations in Myelodysplastic Syndromes. Blood. 130. 586–586. 2 indexed citations
14.
Zhang, Weina, et al.. (2016). Prevalence of congenital cleft lip and/or palate in Guangdong province, 2011-2015. 10(5). 333–336. 1 indexed citations
15.
Lü, Wei, Jun Zheng, Xudong Pan, et al.. (2015). A massive right-to-left shunt in volume-loaded donor heart. ASVIDE. 2(1).
16.
Deng, Zhenzhen, Chunjiang Wang, Zuojun Li, Bing Li, & Shikun Liu. (2013). Peginterferon alpha versus other antiviral regimes for Chinese HBeAg-positive chronic hepatitis B patients.. PubMed. 38(12). 1193–207. 1 indexed citations
17.
Yu, Guangrong, et al.. (2013). Treatment outcomes of buttress plating in treatment of posterior pilon fractures. Zhonghua chuangshang zazhi. 29(3). 243–248. 1 indexed citations
18.
19.
Zhu, Ru‐Yi, et al.. (2009). Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates in Guangdong, China.. PubMed. 62(4). 270–4. 7 indexed citations
20.
Wang, Xin, Bing Li, Baojun Chen, et al.. (2003). [Relationship between the patients' knowledge on hypertension prevention and control and the rate on blood pressure control].. PubMed. 24(12). 1082–5. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Libo Wang Breakdown of academic impact, for papers by Chee‐Kiat Tan Breakdown of academic impact, for papers by George Sourvinos Breakdown of academic impact, for papers by Masaki Fujita Breakdown of academic impact, for papers by Richard T. Bryan Breakdown of academic impact, for papers by Edward Yu Breakdown of academic impact, for papers by Hans‐Peter Marti Breakdown of academic impact, for papers by Dirk Theegarten Breakdown of academic impact, for papers by Vincenzo Esposito Breakdown of academic impact, for papers by Dirk M. Elston
Rankless by CCL
2026